[1] BUNDRED NJ, BARNES NL, RUTGERS E, et al. Is axillary lymph node clear ance required in node-positive breast cancer[J]. Nat Rev Clin Oncol, 2015, 12(1): 55. doi: 10.1038/nrclinonc.2014.188
[2] JOO JH, KIM SS, SON BH, et al. Evaluation of the prognostic stage in the 8th edition of the American joint committee on cancer in pa tients with breast cancer and internal mammary lymph node metas tasis[J]. Anticancer Res, 2018, 38(9): 5357. doi: 10.21873/anticanres.12864
[3] 中国临床肿瘤学会乳腺癌专家委员会发布. 2021年CSCO《乳腺癌诊疗指南》更新要点解读[J]. 中国肿瘤外科杂志, 2021, 13(3): 209. doi: 10.3969/j.issn.1674-4136.2021.03.001
[4] 方三高, 魏建国, 陈真伟. WHO(2019)乳腺肿瘤分类[J]. 临床与实验病理学杂志, 2020, 36(6): 755.
[5] 郭斌. 乳腺癌病人腋窝淋巴结转移相关因素分析[J]. 蚌埠医学院学报, 2021, 46(2): 206.
[6] 王宋, 权毅. Luminal A型乳腺癌发生腋窝淋巴结转移的风险因素分析[J]. 中国普外基础与临床杂志, 2021, 28(6): 789.
[7] 周子君, 古林, 张乃千, 等. T1a~1b期老年乳腺癌腋窝淋巴结转移的相关影响因素[J]. 中国老年学杂志, 2021, 41(19): 4209. doi: 10.3969/j.issn.1005-9202.2021.19.016
[8] 刘信礼, 王雯, 牛学才, 等. 早期浸润性乳腺癌患者腋窝淋巴结转移的影响因素分析[J]. 山东医药, 2021, 61(28): 62. doi: 10.3969/j.issn.1002-266X.2021.28.015
[9] ANDERSSON Y, BERGKVIST L, FRISELL J, et al. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes[J]. Breast Cancer Res Treat, 2018, 171(2): 359. doi: 10.1007/s10549-018-4820-0
[10] SUSINI T, NORI J, OLIVIERIL S, et al. Predicting the status of axillary lymph nodes in breast cancer: a multiparameter approach including axillary ultra-sound scanning[J]. Breast, 2009, 18: 103. doi: 10.1016/j.breast.2009.02.001
[11] WU JL, TSENG HS, YANG LH, et al. Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor[J]. Med Sci Monit, 2014, 8(20): 577.
[12] 王晓芳, 徐新宇, 许里, 等. 胃癌组织miR-203、miR-4317的表达及临床意义[J]. 现代生物医学进展, 2021, 21(3): 480.
[13] WANG C, ZHENG X, SHEN C, et al. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells[J]. J Exp Clin Cancer Res, 2012, 31(1): 58. doi: 10.1186/1756-9966-31-58
[14] 赵高传, 陈卿奇, 庞莉, 等. 血清miR-144及miR-203表达水平对胃癌诊断及预后评估的价值[J]. 中国免疫学杂志, 2021, 37(3): 351. doi: 10.3969/j.issn.1000-484X.2021.03.017
[15] GAO G, GE R, LI Y, et al. Luteolin exhibits anti-breast cancer property through up-regulating miR-203[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 3265. doi: 10.1080/21691401.2019.1646749
[16] 杨雯迪, 李亚军. miR-203a-3p靶向调控VEGF-C表达对卵巢癌恶性生物学特征的影响[J]. 中国妇幼健康研究, 2022, 33(1): 66.
[17] ZHANG L, WANG H, LI C, et al. VEGF-A/Neuropilin 1 pathway confers cancer stemness via activating wnt/β-Catenin axis in breast cancer cells[J]. Cell Physiol Biochem, 2017, 44(3): 1251. doi: 10.1159/000485455